Algo version: 0.98b
Recce Pharmaceuticals Ltd is listed at the ASX Exchange
Recce Pharmaceuticals Ltd [RCE.AX]
ASX Sector: Industry:Pharmaceuticals, Biotechnology & Life Sciences

Is Recce Pharmaceuticals Ltd stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Recce Pharmaceuticals Ltd 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $0.215, you would have made a profit of $0.330 per share or 153.49%

No, the average daily trading liquidity for Recce Pharmaceuticals Ltd is $200 541 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Recce Pharmaceuticals Ltd has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Recce Pharmaceuticals Ltd to be medium [0.7 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.